Literature DB >> 2986821

Atypical hyperplastic lesions of the female breast. A long-term follow-up study.

D L Page, W D Dupont, L W Rogers, M S Rados.   

Abstract

A total of 10,542 breast biopsy specimens obtained between 1950 and 1968 were studied. Examples of atypical "ductal" (ADH) and atypical lobular hyperplasia (ALH), defined as having only some features of carcinoma in situ (CIS), were diagnosed in 3.6% of these specimens. In the same series, CIS was diagnosed in 1.7% of biopsy specimens excluding those with invasive cancer. The subsequent risk of invasive breast carcinoma after ALH or ADH was 4-5 times that of the general population. Follow-up was 90% successful and extended 17 years after biopsy. History of breast cancer in a mother, sister, or daughter doubled the risk of subsequent invasive carcinoma development (to 8 times for ALH and 10 times for ADH). The authors conclude that among the epithelial hyperplastic lesions of the human breast, a minority may be recognized by their resemblance to CIS which have a clinically significant elevation of subsequent breast cancer risk. This risk is one-half that of CIS.

Entities:  

Mesh:

Year:  1985        PMID: 2986821     DOI: 10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  183 in total

Review 1.  The basic pathology of human breast cancer.

Authors:  E Mallon; P Osin; N Nasiri; I Blain; B Howard; B Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

2.  Epithelial Proliferative Lesions and Carcinomas in Fibroadenomas of the Breast.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

3.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

4.  Fibroadenosis of the breast does not require excision biopsy.

Authors:  A P Corder; R Carpenter; J A Smallwood; C D Johnson
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

Review 5.  The molecular pathology of breast cancer progression.

Authors:  Alessandro Bombonati; Dennis C Sgroi
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

6.  Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.

Authors:  Rulla M Tamimi; Graham A Colditz; Yihong Wang; Laura C Collins; Rong Hu; Bernard Rosner; Hanna Y Irie; James L Connolly; Stuart J Schnitt
Journal:  Breast Cancer Res Treat       Date:  2011-01-01       Impact factor: 4.872

7.  Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.

Authors:  Rulla M Tamimi; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

8.  Natural history of in situ breast cancer in a defined population.

Authors:  W J Temple; M Jenkins; F Alexander; W S Hwang; L H Marx; A W Lees; H T Williams; M G Pambrun
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

9.  Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.

Authors:  Heather J Baer; Laura C Collins; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

10.  Benign breast disease: the cost of the service and the cost to the patient.

Authors:  M Baum
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.